ProKidney Corp (PROK)
2.27
+0.04
(+1.79%)
USD |
NASDAQ |
Jun 26, 16:00
2.274
0.00 (0.00%)
After-Hours: 20:00
ProKidney Net Income (Quarterly): -9.492M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -9.492M |
December 31, 2023 | -5.701M |
September 30, 2023 | -10.98M |
June 30, 2023 | -9.118M |
March 31, 2023 | -9.665M |
December 31, 2022 | -6.487M |
September 30, 2022 | -11.93M |
Date | Value |
---|---|
June 30, 2022 | -22.13M |
March 31, 2022 | -67.49M |
December 31, 2021 | -13.67M |
September 30, 2021 | -17.14M |
June 30, 2021 | -12.72M |
March 31, 2021 | -11.61M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-67.49M
Minimum
Mar 2022
-5.701M
Maximum
Dec 2023
-16.01M
Average
-11.61M
Median
Mar 2021
Net Income (Quarterly) Benchmarks
Bio-Path Holdings Inc | -3.157M |
BioSig Technologies Inc | -3.402M |
NKGen Biotech Inc | -5.382M |
Windtree Therapeutics Inc | 10.22M |
Veru Inc | -10.03M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 40.08M |
EPS Diluted (Quarterly) | -0.16 |
Enterprise Value | 1.407B |
Earnings Yield | -25.11% |